A1BG | Alpha-1-B glycoprotein | Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
A2M | Alpha-2-macroglobulin | Cancer-related genes Candidate cardiovascular disease genes Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
A2ML1 | Alpha-2-macroglobulin-like 1 | Predicted secreted proteins
| | | | | Tissue enriched |
A4GNT | Alpha-1,4-N-acetylglucosaminyltransferase | Predicted secreted proteins
| | | | | Tissue enriched |
AACS | Acetoacetyl-CoA synthetase | Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
AADAC | Arylacetamide deacetylase | Enzymes
| | | | | Tissue enhanced |
AAMP | Angio-associated, migratory cell protein | Plasma proteins
| | | | | Expressed in all |
AANAT | Aralkylamine N-acetyltransferase | Disease related genes Enzymes Potential drug targets Predicted secreted proteins
| | | | | Tissue enhanced |
AATK | Apoptosis-associated tyrosine kinase | Enzymes Predicted membrane proteins
| | | | | Tissue enhanced |
ABCC3 | ATP-binding cassette, sub-family C (CFTR/MRP), member 3 | Cancer-related genes Predicted membrane proteins Transporters
| | | | | Mixed |
ABCD1 | ATP-binding cassette, sub-family D (ALD), member 1 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
ABCD4 | ATP-binding cassette, sub-family D (ALD), member 4 | Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
ABCG1 | ATP-binding cassette, sub-family G (WHITE), member 1 | Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Expressed in all |
ABHD1 | Abhydrolase domain containing 1 | Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
ABHD10 | Abhydrolase domain containing 10 | Enzymes Mitochondrial proteins Predicted secreted proteins
| | | | | Expressed in all |
ABHD14A | Abhydrolase domain containing 14A | Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
ABHD14A-ACY1 | ABHD14A-ACY1 readthrough (NMD candidate) | | | | | | Mixed |
ABHD15 | Abhydrolase domain containing 15 | Predicted secreted proteins
| | | | | Mixed |
ABHD16A | Abhydrolase domain containing 16A | Predicted membrane proteins
| | | | | Expressed in all |
ABHD8 | Abhydrolase domain containing 8 | | | | | | Mixed |
ABI3BP | ABI family, member 3 (NESH) binding protein | Plasma proteins Predicted secreted proteins
| | | | | Mixed |
ABL2 | C-abl oncogene 2, non-receptor tyrosine kinase | Cancer-related genes Enzymes RAS pathway related proteins
| | | | | Expressed in all |
AC005609.1 | Uncharacterized protein; cDNA FLJ34090 fis, clone FCBBF3006399 | | | | | | Not detected |
AC011500.1 | Interleukin-like; Uncharacterized protein | | | | | | Tissue enriched |
AC016586.1 | | Predicted secreted proteins
| | | | | Not detected |
AC027763.2 | Uncharacterized protein | | | | | | Expressed in all |
AC090616.2 | Uncharacterized protein | Predicted secreted proteins
| | | | | Tissue enhanced |
AC092675.3 | Uncharacterized protein | | | | | | Not detected |
AC093157.1 | Uncharacterized protein | Predicted secreted proteins
| | | | | Not detected |
AC106876.2 | Uncharacterized protein | | | | | | Group enriched |
AC114783.1 | Protein LOC339760 | Predicted secreted proteins
| | | | | Tissue enriched |
AC117834.1 | | | | | | | Tissue enhanced |
AC140481.2 | Uncharacterized protein | | | | | | Tissue enriched |
AC145205.1 | | | | | | | Not detected |
ACACB | Acetyl-CoA carboxylase beta | Enzymes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
ACADM | Acyl-CoA dehydrogenase, C-4 to C-12 straight chain | Disease related genes Enzymes Mitochondrial proteins Potential drug targets
| | | | | Expressed in all |
ACAN | Aggrecan | Predicted secreted proteins
| | | | | Mixed |
ACE | Angiotensin I converting enzyme | Candidate cardiovascular disease genes CD markers Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
ACE | Angiotensin-converting enzyme; Uncharacterized protein | Predicted secreted proteins
| | | | | Not detected |
ACHE | Acetylcholinesterase (Yt blood group) | Blood group antigen proteins Enzymes FDA approved drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
ACP1 | Acid phosphatase 1, soluble | Enzymes Plasma proteins
| | | | | Expressed in all |
ACP5 | Acid phosphatase 5, tartrate resistant | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins
| | | | | Expressed in all |
ACP6 | Acid phosphatase 6, lysophosphatidic | Enzymes Predicted secreted proteins
| | | | | Expressed in all |
ACPL2 | Acid phosphatase-like 2 | Enzymes Predicted secreted proteins
| | | | | Expressed in all |
ACPP | Acid phosphatase, prostate | Cancer-related genes Enzymes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
ACR | Acrosin | Enzymes Predicted secreted proteins
| | | | | Tissue enriched |
ACRBP | Acrosin binding protein | Predicted secreted proteins
| | | | | Tissue enriched |
ACRV1 | Acrosomal vesicle protein 1 | Predicted secreted proteins
| | | | | Tissue enriched |
ACSF2 | Acyl-CoA synthetase family member 2 | Mitochondrial proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
ACSF3 | Acyl-CoA synthetase family member 3 | Disease related genes Mitochondrial proteins Predicted membrane proteins
| | | | | Expressed in all |